Dolnoslaskie Centrum Onkologii Pulmonologii I Hematologii

At Dolnoslaskie Centrum Onkologii Pulmonologii I Hematologii, clinical research in hematologic oncology focuses on neoplasms affecting the blood and bone marrow, especially aggressive forms of leukemia and related precursor disorders. The trials are designed to explore new treatment options and better understand how emerging therapies may help patients whose disease has returned or no longer responds to standard care.

• Acute Myeloid Leukemia and Acute Myeloid Leukemia with or without NPM1 Mutation
• Relapsed or Refractory High-Risk Myelodysplastic Syndrome
• Evaluation of a new therapy approach aimed at improving anti-tumor and anti-leukemic activity

This research area includes studies of RVU120 alone and in combination with Venetoclax, with the goal of assessing treatment effectiveness and potential benefit for patients with difficult-to-treat acute myeloid leukemia and myelodysplastic syndrome.